MaxCyte, Inc. (MXCT)
NASDAQ: MXCT · Real-Time Price · USD
4.240
+0.100 (2.42%)
At close: Dec 20, 2024, 4:00 PM
4.241
0.00 (0.01%)
After-hours: Dec 20, 2024, 4:01 PM EST
MaxCyte Employees
MaxCyte had 143 employees as of December 31, 2023. The number of employees increased by 18 or 14.40% compared to the previous year.
Employees
143
Change (1Y)
18
Growth (1Y)
14.40%
Revenue / Employee
$318,874
Profits / Employee
-$249,902
Market Cap
438.50M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
InnovAge Holding | 2,350 |
Ginkgo Bioworks Holdings | 1,218 |
MeiraGTx Holdings | 425 |
UroGen Pharma | 201 |
AnaptysBio | 117 |
Kodiak Sciences | 111 |
Alumis | 109 |
Theravance Biopharma | 99 |
MXCT News
- 12 days ago - MaxCyte Announces Streamlined Operations and Raises 2024 Revenue Guidance - GlobeNewsWire
- 5 weeks ago - MaxCyte Celebrates 25 Years of Innovation Driving Cell Engineering-Based Therapeutics - GlobeNewsWire
- 6 weeks ago - MaxCyte, Inc. (MXCT) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - MaxCyte Reports Third Quarter 2024 Financial Results and Updates Full Year 2024 Guidance - GlobeNewsWire
- 7 weeks ago - MaxCyte to Participate in Two Upcoming Investor Conferences - GlobeNewsWire
- 2 months ago - MaxCyte Appoints Cynthia Collins to its Board of Directors - GlobeNewsWire
- 2 months ago - MaxCyte to Report Third Quarter 2024 Financial Results on November 6, 2024 - GlobeNewsWire
- 2 months ago - MaxCyte Appoints Ali Soleymannezhad as Chief Commercial Officer - GlobeNewsWire